Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting

We improved a previous pharmacological target adverse‐event (TAE) profile model to predict adverse events (AEs) on US Food and Drug Administration (FDA) drug labels at the time of approval. The new model uses more drugs and features for learning as well as a new algorithm. Comparator drugs sharing s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Ther
Main Authors: Schotland, Peter, Racz, Rebecca, Jackson, David B., Soldatos, Theodoros G., Levin, Robert, Strauss, David G., Burkhart, Keith
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246740/
https://ncbi.nlm.nih.gov/pubmed/33090463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados